AZZ Inc. Stock 12‑Month Price Target Raised to $163.44, Implies 26% Upside

AZZ INC (AZZ) filed an SEC Form 8-K — Regulation FD Disclosure. N Y S E : A Z Z | I N V E S T O R P R E S E N T A T I O N North America's Leading Independent Metal Coatings Platform A differentiated, high-margin hot-dip galvanizing and coil coating company, compounding earnings through secular tailwinds, disciplined capital allocation, and a

AZZ Inc. raised its fiscal 2027 guidance, projecting sales of $1.825–1.875B, adjusted EBITDA of $380–420M, and adjusted EPS of $7.00–7.30. The company also announced a $20M buyback and a $0.24 dividend. Barclays initiated coverage with a $140 price target and an equal-weight rating.

AZZ Inc reported Q2 2027 earnings with record sales, raised guidance, and a 29% EPS jump. The company cited strong demand in Metal Coatings and the Seattle Galvanizing acquisition's performance. Challenges include softer HVAC volume, tight steel substrate markets, and potential margin pressure from tariffs. The debt reduction target was lowered to $100-$140 million due to the acquisition.

AZZ Inc. reported Q2 earnings, highlighting the acquisition of Seattle Galvanizing and organic expansions. Sales grew in construction, industrial, and transportation sectors. The company raised its fiscal 2027 outlook, expecting sales of $1.825B-$1.875B and adjusted EBITDA of $380M-$420M. AZZ also updated its debt reduction target due to the acquisition.

AZZ reported Q2 2027 earnings with record sales of $486.9M, up 16.7% YoY. Metal Coatings sales rose 22.9%, while Precoat Metals sales increased 11.5%. Adjusted EPS grew 29% to $2.00. The company completed the Seattle Galvanizing acquisition and is expanding capacity in key markets. Operating cash flow was $102.8M, with adjusted EBITDA at $110.9M. The Washington, Missouri facility is ramping up as planned, contributing to profitability.

Barclays initiated coverage on AZZ Inc. (NYSE:AZZ) with an Equalweight rating and $140 price target, citing its market position and growth prospects. The stock trades at $136.71, below both the target and InvestingPro’s Fair Value of $139.07. Barclays noted AZZ’s pricing power, market share gains, and accretive greenfield plant, but believes positives are reflected in the share price.